Cabaletta Bio, Inc. (CABA) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of Cabaletta Bio, Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cabaletta Bio, Inc. logo
CABA
Cabaletta Bio, Inc.
$329M
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Opus Genetics, Inc. logo
IRD
Opus Genetics, Inc.
$362M
$4.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CABA vs IRD

growth of $100 · dividends reinvested · last 2y
CABA -47.3% (-27.4%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$53$340
CABA IRD

CABA vs IRD: by the numbers

  • •IRD is the larger company ($362M vs $329M market cap).
  • •Both run net losses; CABA's is the smaller (0.00% vs -1091.82% net margin).

Metrics side by side

Valuation

MetricCABAIRD
P/S ratioN/A36.69
P/B ratio1.56N/A

Profitability

MetricCABAIRD
Gross margin0.00%99.87%
Operating margin0.00%-271.90%
Net margin0.00%-1091.82%
ROE-86.10%N/A
ROIC-85.56%-59.29%

Growth (annualized)

MetricCABAIRD
Revenue CAGR (5Y)N/A150.49%
Total return CAGR (5Y)-28.71%N/A

Go deeper

Full CABA analysisFull IRD analysisInteractive comparison tool

Dig into the metrics

Cabaletta Bio ROEOpus Genetics ROECabaletta Bio operating marginOpus Genetics operating marginCabaletta Bio revenue growthOpus Genetics revenue growthCabaletta Bio free cash flowOpus Genetics free cash flow

Cabaletta Bio & Opus Genetics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.